LA ROCHE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LA ROCHE PHARMA
Largest movements
- Tangible fixed assets -€168,862
down €168,862 (-26.3%), from €643,275 to €474,412
of which Land and buildings: -€205,118
- Intangible fixed assets -€139,579
down €139,579 (-17.7%), from €787,475 to €647,896
- Cash -€104,226
down €104,226 (-17.8%), from €586,112 to €481,886
mainly Other debts (-€370,229) and Contributions, distributions and other (-€126,432)
- Receivables within one year +€30,418
up €30,418 (+27.6%), from €110,153 to €140,571
- Other debts -€370,229
down €370,229 (-74.0%), from €500,561 to €130,332
- Current portion of long-term debt -€54,163
down €54,163 (-40.4%), from €134,033 to €79,870
- Debts after one year +€47,397
up €47,397 (+7.7%), from €615,402 to €662,798
of which Financial debts: +€47,397
- Reserves -€26,375
down €26,375 (-4.2%), from €629,113 to €602,738
- Gross operating margin +€29,232
up €29,232 (+5.8%), from €507,524 to €536,756
- Depreciation -€22,625
down €22,625 (-11.6%), from €195,799 to €173,175
- Staff costs +€19,774
up €19,774 (+15.9%), from €124,335 to €144,109
- Taxes +€11,686
up €11,686 (+16.2%), from €72,114 to €83,800
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,346,902 | €1,969,493 | -€377,408 | -16.1% |
| Fixed assets | 21/28 | €1,430,749 | €1,122,308 | -€308,441 | -21.6% |
| Intangible fixed assets | 21 | €787,475 | €647,896 | -€139,579 | -17.7% |
| Tangible fixed assets | 22/27 | €643,275 | €474,412 | -€168,862 | -26.3% |
| Land and buildings | 22 | €637,254 | €432,136 | -€205,118 | -32.2% |
| Furniture and vehicles | 24 | €6,021 | €42,276 | +€36,255 | +602% |
| Current assets | 29/58 | €916,152 | €847,185 | -€68,967 | -7.5% |
| Stocks and contracts in progress | 3 | €219,151 | €220,090 | +€939 | +0.4% |
| Stocks | 30/36 | €219,151 | €220,090 | +€939 | +0.4% |
| Amounts receivable within one year | 40/41 | €110,153 | €140,571 | +€30,418 | +27.6% |
| Trade receivables | 40 | €110,153 | €140,571 | +€30,418 | +27.6% |
| Cash at bank and in hand | 54/58 | €586,112 | €481,886 | -€104,226 | -17.8% |
| Deferred charges and accrued income | 490/1 | €735 | €4,638 | +€3,903 | +531% |
| Total equity and liabilities | 10/49 | €2,346,902 | €1,969,493 | -€377,408 | -16.1% |
| Equity | 10/15 | €877,972 | €851,597 | -€26,375 | -3.0% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Reserves | 13 | €629,113 | €602,738 | -€26,375 | -4.2% |
| Distributable reserves | 133 | €629,113 | €602,738 | -€26,375 | -4.2% |
| Profit (loss) carried forward | 14 | €148,859 | €148,859 | = | 0.0% |
| Amounts payable | 17/49 | €1,468,930 | €1,117,897 | -€351,034 | -23.9% |
| Amounts payable after more than one year | 17 | €615,402 | €662,798 | +€47,397 | +7.7% |
| Financial debts | 170/4 | €366,369 | €413,765 | +€47,397 | +12.9% |
| Other amounts payable | 178/9 | €249,033 | €249,033 | = | 0.0% |
| Amounts payable within one year | 42/48 | €832,908 | €441,557 | -€391,351 | -47.0% |
| Current portion of amounts payable after more than one year | 42 | €134,033 | €79,870 | -€54,163 | -40.4% |
| Financial debts | 43 | €13,617 | €13,568 | -€49 | -0.4% |
| Credit institutions | 430/8 | €13,617 | €13,568 | -€49 | -0.4% |
| Trade debts | 44 | €128,870 | €149,727 | +€20,856 | +16.2% |
| Suppliers | 440/4 | €128,870 | €149,727 | +€20,856 | +16.2% |
| Taxes, remuneration and social security | 45 | €55,827 | €68,061 | +€12,234 | +21.9% |
| Taxes | 450/3 | €46,690 | €48,395 | +€1,705 | +3.7% |
| Remuneration and social security | 454/9 | €9,137 | €19,666 | +€10,529 | +115% |
| Other amounts payable | 47/48 | €500,561 | €130,332 | -€370,229 | -74.0% |
| Accrued charges and deferred income | 492/3 | €20,620 | €13,541 | -€7,079 | -34.3% |
| Remuneration, social security and pensions | 62 | €124,335 | €144,109 | +€19,774 | +15.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €195,799 | €173,175 | -€22,625 | -11.6% |
| Other operating charges | 640/8 | €8,555 | €5,734 | -€2,821 | -33.0% |
| Gross operating margin | 9900 | €507,524 | €536,756 | +€29,232 | +5.8% |
| Operating profit (loss) | 9901 | €178,835 | €213,738 | +€34,903 | +19.5% |
| Financial income | 75/76B | €2,633 | €5,636 | +€3,002 | +114% |
| Recurring financial income | 75 | €2,633 | €5,636 | +€3,002 | +114% |
| Financial charges | 65/66B | €37,298 | €35,517 | -€1,781 | -4.8% |
| Recurring financial charges | 65 | €37,298 | €35,517 | -€1,781 | -4.8% |
| Profit (loss) for the period before taxes | 9903 | €144,170 | €183,857 | +€39,687 | +27.5% |
| Income taxes | 67/77 | €72,114 | €83,800 | +€11,686 | +16.2% |
| Profit (loss) for the period | 9904 | €72,056 | €100,057 | +€28,001 | +38.9% |
| Profit (loss) for the period to be appropriated | 9905 | €72,056 | €100,057 | +€28,001 | +38.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.